Search clinical trials for: GSI-953

Total 1825 results

Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Completed

Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer

Prostate Cancer

United States
University Medical Center Groningen
GGZ Drenthe Mental Health Institution

Recruiting

Lifestyle InterVEntion Study in General Practice: LIVES - GP (LIVES-GP)

Cardiovascular Diseases | Depression, Unipolar

Netherlands
JS InnoPharm, LLC

Recruiting

ERK Inhibitor JSI-1187 in Advanced Solid Tumors

Melanoma | NSCLC | Solid Tumor

China
Florida International University

Recruiting

A Single-Session Intervention for Families on Waitlists for Child Anxiety Treatment (aSSI)

Anxiety Disorders

United States
Fujian Akeylink Biotechnology Co., Ltd.

Recruiting

Evaluation of The Safety, Efficacy and Pharmacokinetic Characteristics of GST-HG141 Tablets

Chronic Hepatitis b

China
GlycoMimetics Incorporated

Terminated

A Study to Determine Safety and Tolerability of GMI-1359 in Subjects With HR+ Metastatic Breast Cancer

Breast Cancer | Breast Cancer Metastatic | HR+ Metastatic Breast Cancer

United States
Astex Pharmaceuticals, Inc.

Withdrawn

Study of SGI-1776, a PIM Kinase Inhibitor, in Subjects With Relapsed/Refractory Leukemias

Relapsed/Refractory Leukemias

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating PSI-697 in Patients With Scleritis

Scleritis
Chang Gung Memorial Hospital

Recruiting

Image Characteristic and Longitudinal Follow up of 18F-PMPBB3 (APN-1607) PET for Progressive Supranuclear Palsy

Progressive Supranuclear Palsy

Taiwan
AbbVie

Completed

A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment

Parkinson's Disease (PD)

United States
GlaxoSmithKline
Aeras

Completed

Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342

Tuberculosis

Belgium
AVEO Pharmaceuticals, Inc.

Terminated

A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols

Solid Tumors

United States, Canada, Netherlands, India, Russian Federation, Ukraine
AbbVie

Completed

Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participants With Parkinson's Disease

Parkinson's Disease

United States
3M

Unknown

EXD-959 Orthodontic Brackets and EXD-961 Related Instruments Trial

Malocclusion

United States
Avanir Pharmaceuticals

Completed

Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)

Stroke | Parkinson's Disease | Traumatic Brain Injury | Alzheimer's Disease

United States
National Cancer Institute (NCI)

Completed

Gene Therapy in Treating Patients With Ovarian Cancer

Ovarian Cancer

United States
GlaxoSmithKline

Terminated

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease

Tuberculosis

Taiwan, Estonia
Astellas Pharma Global Development, Inc.

Completed

A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body

Advanced Solid Tumors | Pharmacokinetics of 14C-OSI-906

United States
GlaxoSmithKline

Completed

Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older

Influenza

Spain, United States
M.D. Anderson Cancer Center
Cytogen Corporation

Completed

Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases

Breast Cancer | Bone Metastases

United States
GGZ Centraal
University Medical Center Groningen; Maastricht University

Terminated

Deep Brain Stimulation for Patients With Tardive Dyskinesia and or Dystonia

Tardive Dyskinesia | Tardive Dystonia

Netherlands
Genaera Corporation

Terminated

A Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration

Macular Degeneration

United States
Changchun GeneScience Pharmaceutical Co., Ltd.
Syneos Health

Recruiting

A Study to Assess Safety and Tolerability of GS1-144 in Healthy Volunteers

Vasomotor Symptoms | Adult Healthy Volunteers

Australia
Fujian Cosunter Pharmaceutical Co. Ltd

Recruiting

Phase I Study of GST-HG151 Tablets in Healthy Volunteers

Healthy Volunteers

China
Pfizer

Completed

Study Evaluating the Effects of PSI-697 on Platelets in Subjects Who Smoke

Healthy
GlycoMimetics Incorporated

Completed

Placebo-controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1271 in Healthy Volunteers

Healthy Adult Subjects

United States
Heinrich-Heine University, Duesseldorf

Completed

Deep Brain Stimulation of the Globus Pallidus in Huntington's Disease

Huntington's Disease

Germany
Neuralstem Inc.

Completed

Single-Dose Pharmacokinetics (PK) Study of Novel Neurogenic Compound NSI-189

Depression

United States
Genaera Corporation

Completed

A Single Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers

Obesity | Diabetes Mellitus

United States
Changchun GeneScience Pharmaceutical Co., Ltd.

Recruiting

A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Oral Dose Escalation of GS1-144 Tablets and the Effects of Food on the Pharmacokinetics of GS1-144 in a Chinese Population

Healthy Volunteer | Vasomotor System; Labile

China
Cairo University

Not yet recruiting

Patient Specific Implant Versus Miniplates for Advancement of Hypoplastic Maxilla

Cleft Lip and Palate
Abbott Medical Devices

Withdrawn

CSI Percutaneous Ventricular Assist Device (pVAD) Second in Human Study

Coronary Artery Disease

Georgia
GlycoMimetics Incorporated

Terminated

Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease

Sickle Cell Disease | Sickle Cell Anemia | Vaso-occlusive Crisis | Pain Crisis | Sickle Cell Disorders

United States, Canada
GlycoMimetics Incorporated

Completed

A Study to Evaluate the Effect of Age on the Pharmacokinetics, Safety and Tolerability of IV Rivipansel.

Healthy

United States
HelixBind, Inc.

Unknown

Assessment of Assay for Rapid Identification of Bloodstream Infections From Whole Blood

Candidemia | Bacteremia

United States
GlycoMimetics Incorporated
Celerion

Completed

Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1359 in Healthy Volunteers

Healthy

United States
Northwell Health
DepYmed Inc.

Terminated

Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Sangamo Therapeutics

Active, not recruiting

Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX (LTFU)

Hemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis II

United States
Millennium Pharmaceuticals, Inc.

Withdrawn

Efficacy and Safety of TAK-653 in Treatment-Resistant Depression

Treatment-Resistant Depression
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Unknown

ERA-923 in Treating Postmenopausal Women With Metastatic Breast Cancer

Breast Cancer

United States
GlaxoSmithKline

Completed

A Study to Assess the Relative Bioavailability of Four New Formulations of GSK1605786 in Healthy Subjects

Crohn's Disease

United States
GlaxoSmithKline

Completed

Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old

Influenza

Thailand, Philippines
Abbott Medical Devices
Clinical Accelerator

Completed

Cardiovascular Systems Inc. (CSI) pVAD First in Human Study

Coronary Artery Disease

Georgia
Qu Biologics Inc.

Terminated

QBECO SSI for Clinical and Endoscopic Remission in Moderate to Severe Crohn's Disease

Crohn Disease

Canada
GlycoMimetics Incorporated

Completed

A Study to Evaluate the Effect of IV Doses of Rivipansel in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function

Moderate Hepatic Impairment | Normal Hepatic Function

United States
GlycoMimetics Incorporated

Completed

A Study to Evaluate the Effect of IV Doses of Rivipansel on Subjects With Renal Impairment and in Healthy Subjects

Healthy | Renal Impairment

United States
Johannes Gutenberg University Mainz
Deutsche Rentenversicherung; Koblenz University of Applied Science

Completed

Implementation of the Internet-based Aftercare Program 'GSA-Online Plus'

Implementation

Germany
Takeda

Completed

A Phase 1 Positron Emission Tomography Study to Measure Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935

Epilepsy, Molecular Mechanisms of Pharmalogical Action, Protective Agents

United States
Pfizer

Completed

A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1

HIV-1

United Kingdom, South Africa, Australia, Canada, Italy, Poland, Switzerland, Argentina, Mexico
AVEO Pharmaceuticals, Inc.

Completed

A Study of Tivozanib (AV-951), an Oral VEGF Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell Carcinoma

Carcinoma, Renal Cell

Ukraine, India, Russian Federation

3

Subscribe